Valerio Therapeutics Raises $47.0M in Funding

Ingenico

Ingenico is the global leader in payment acceptance and services. We support our customers, and their customers to do more with payments. Active in 32 countries, with over 3,000 employees we have been at the forefront of the commerce landscape for over four decades. With tens of millions of payment devices deployed worldwide, powered by over 2,500 apps, the company is servicing the needs of millions of consumers every day. Through our advanced integrated solutions and network of partnerships, we simplify the world of payments and bring value added services to move commerce forward.

Innate Pharma

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca. Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.

CHARGEPOLY

For several years, Chargepoly has established itself as a trusted partner for the electrification of heavy-duty and commercial vehicle fleets. The company develops and operates electric vehicle charging infrastructure and services designed to meet the intensive needs of logistics and transportation.